Compass Therapeutics (CMPX) shares soared to a 52-week high, reaching a price level of $2.68. According to InvestingPro data, analysts have set price targets ranging from $4 to $32, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback